Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.

MLA

Braun, Rüdiger, et al. “Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.” Cells, vol. 12, no. 4, Feb. 2023. EBSCOhost, https://doi.org/10.3390/cells12040587.

APA

Braun, R., Lapshyna, O., Watzelt, J., Drenckhan, M., Künstner, A., Färber, B., Hael, A. A. M., Bolm, L., Honselmann, K. C., Konukiewitz, B., Castven, D., Spielmann, M., Gorantla, S. P., Busch, H., Marquardt, J.-U., Keck, T., Wellner, U. F., & Ungefroren, H. (2023). Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Cells, 12(4). https://doi.org/10.3390/cells12040587

Chicago

Braun, Rüdiger, Olha Lapshyna, Jessica Watzelt, Maren Drenckhan, Axel Künstner, Benedikt Färber, Ahmed Ahmed Mohammed Hael, et al. 2023. “Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.” Cells 12 (4). doi:10.3390/cells12040587.